Results 1 to 10 of about 410 (125)

ASIA and BIA-ALCL as adverse reactions to silicone breast implants [PDF]

open access: yesRevista Brasileira de Cirurgia Plástica, 2023
Adjuvant-induced autoimmune/inflammatory syndrome leads to capsular contracture and fibrosis from the oxidation that takes place in silicone.
Natalia Silva Zahdi   +3 more
doaj   +1 more source

Adjuvant-induced autoimmune syndrome triggered by silicone breast implants: systematic review [PDF]

open access: yesRevista Brasileira de Cirurgia Plástica, 2022
Adjuvant-induced autoimmune syndrome (ASIA) and its diagnostic criteria were described by Shoenfeld in 2011, relating symptoms of autoimmunity to adjuvants, such as silicone, present in breast implants.
Caio Munaretto Giacomazzo   +5 more
doaj   +1 more source

Vaccination for Respiratory Syncytial Virus: A Narrative Review and Primer for Clinicians

open access: yesVaccines, 2023
Respiratory syncytial virus (RSV) poses a significant burden on public health, causing lower respiratory tract infections in infants, young children, older adults, and immunocompromised individuals.
Kay Choong See
doaj   +1 more source

Liposomes as Immunological Adjuvants [PDF]

open access: yesNature, 1974
ADJUVANTS are widely used to increase antibody formation in experimental animals, for example, Freund's incomplete adjuvant, a water-in-oil emulsion containing the antigen, and Freund's complete adjuvant, which is the same but with killed tubercle bacilli.
Allison, A C, Gregoriadis, G
openaire   +4 more sources

Application of built-in adjuvants for epitope-based vaccines [PDF]

open access: yesPeerJ, 2019
Several studies have shown that epitope vaccines exhibit substantial advantages over conventional vaccines. However, epitope vaccines are associated with limited immunity, which can be overcome by conjugating antigenic epitopes with built-in adjuvants (e.
Yao Lei   +6 more
doaj   +2 more sources

Immune Adjuvant Therapy With Interleukin-7 in a Lymphopenic Patient With Aplastic Anemia and Mucormycosis

open access: yesCritical Care Explorations, 2023
BACKGROUND:. We report the case of a patient with aplastic anemia and pancytopenia on immune-suppressive therapy who developed invasive pulmonary infection with mucormycosis and was treated with immune adjuvant therapy. CASE SUMMARY:. Given the patient’s
Zachary D. Crees, MD   +8 more
doaj   +1 more source

Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination

open access: yesScientific Reports, 2022
Infection is the most common cause of mortality early in life, yet the broad potential of immunization is not fully realized in this vulnerable population. Most vaccines are administered during infancy and childhood, but in some cases the full benefit of
David J. Dowling   +16 more
doaj   +1 more source

SARS-CoV-2 vaccine-triggered autoimmunity: Molecular mimicry and/or bystander activation of the immune system [PDF]

open access: yesBioImpacts, 2023
Induced autoimmunity or autoinflammatory-like conditions as a rare vaccine-related adverse event have been reported following COVID-19 vaccination.
Azam Safary   +3 more
doaj   +1 more source

Near-infrared laser adjuvant for influenza vaccine. [PDF]

open access: yesPLoS ONE, 2013
Safe and effective immunologic adjuvants are often essential for vaccines. However, the choice of adjuvant for licensed vaccines is limited, especially for those that are administered intradermally.
Satoshi Kashiwagi   +21 more
doaj   +1 more source

Intranasal immunization with inactivated chlamydial elementary bodies formulated in VCG-chitosan nanoparticles induces robust immunity against intranasal Chlamydia psittaci challenge

open access: yesScientific Reports, 2021
Vaccines based on live attenuated Chlamydia elementary bodies (EBs) can cause disease in vaccinated animals and the comparably safer inactivated whole EBs are only marginally protective.
Zonghui Zuo   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy